Pediatric neuromodulation for drug‐resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers
Epilepsia Open · 2024
DOI: 10.1002/epi4.12902 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia Open, 2024. Verfasst von Charuta N Joshi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Children's Health, University of Texas Southwest, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Epilepsy, Drug Resistant Epilepsy, Intralaminar Thalamic Nuclei. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neuromodulation via Responsive Neurostimulation (RNS) or Deep Brain Stimulation (DBS) is an emerging treatment strategy for pediatric drug‐resistant epilepsy (DRE). Knowledge gaps exist in patient selection, surgical technique, and perioperative care. Here, we use an expert survey to clarify practices. Thirty‐two members of the Pediatric Epilepsy Research Consortium were surveyed using REDCap. Respondents were from 17 pediatric epilepsy centers (missing data in one): Four centers implant RNS only while 13 implant both RNS and DBS. Thirteen RNS programs commenced in or before 2020, and 10 of 12 DBS programs began thereafter. The busiest six centers implant 6–10 new RNS devices per year; all DBS programs implant 50%) was reported by 81% (13/16) of centers. RNS and DBS are rapidly evolving treatment modalities for safe and effective treatment of pediatric DRE. There is increasing interest in multicenter collaboration to gain knowledge and facilitate dialogue. Plain language summary We surveyed 32 pediatric epilepsy centers in USA to highlight current practices of intracranial neuromodulation. Of the 17 that replied, we found that most centers are implanting thalamic targets in pediatric drug‐resistant epilepsy using the RNS device. DBS device is starting to be used in pediatric epilepsy, especially after 2020. Different strategies for target identification are enumerated. This study serves as a starting point for future collaborative research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Health, University of Texas Southwest, Dallas, Texas, USA.
- Department of Neurology, Division of Child Neurology, Norton Neuroscience Institute, University of Louisville, Louisville, Kentucky, USA.
- Department of Pediatrics, Children's Hospital Colorado, Section of Neurology, University of Colorado, Aurora, Colorado, USA.
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Pediatric Neurosurgery, Benioff Children's Hospital, UCSF Weill Institute for Neurosciences, San Francisco, California, USA.
- Department of Neurosurgery, Section of Pediatric Neurosurgery, Oklahoma Children's Hospital, University of Oklahoma School of Medicine, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Charuta N Joshi, Cemal Karakas, Krista Eschbach, Debopam Samanta, Steven Wolf, Taylor J Abel, Edward Novotny, Puck Reeders, Adam P Ostendorf, Andrew Knox, Carrie R Muh
Zitieren
APA
Joshi, C. N., Karakas, C., Eschbach, K., Samanta, D., Auguste, K., Desai, V., Singh, R., McGoldrick, P., Wolf, S., Abel, T. J., Novotny, E., Oluigbo, C., Reddy, S. B., Alexander, A., Price, A., Reeders, P., Mcnamara, N., Romanowski, E. F., Mutchnick, I., …, & Muh, C. R. (2024). Pediatric neuromodulation for drug‐resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers. Epilepsia Open. https://doi.org/10.1002/epi4.12902
Vancouver
Joshi CN, Karakas C, Eschbach K, Samanta D, Auguste K, Desai V, et al. Pediatric neuromodulation for drug‐resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers. Epilepsia Open. 2024. doi:10.1002/epi4.12902
BibTeX
@article{Joshi2024,
author = {Joshi, Charuta N and Karakas, Cemal and Eschbach, Krista and Samanta, Debopam and Auguste, Kurtis and Desai, Virendra and Singh, Rani and McGoldrick, Patricia and Wolf, Steven and Abel, Taylor J and Novotny, Edward and Oluigbo, Chima and Reddy, Shilpa B and Alexander, Allyson and Price, Angela and Reeders, Puck and Mcnamara, Nancy and Romanowski, Erin Fedak and Mutchnick, Ian and Ostendorf, Adam P and Shaikhouni, Ammar and Knox, Andrew and Aungaroon, Gewalin and Olaya, Joffre and Muh, Carrie R},
title = {Pediatric neuromodulation for drug‐resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centers},
journal = {Epilepsia Open},
year = {2024},
doi = {10.1002/epi4.12902}
}
EUVIMED